Category: Stock Market

Here are three beaten-down ASX shares that have fallen roughly 30% or more over the past six months. REA Group Ltd (ASX: REA), Seek Ltd (ASX: SEK) and Lendlease Group (ASX: LLC) also slipped about 3% on Monday.

The question investors are asking now is whether the sell-off has created a buying opportunity.

REA Group: high quality digital ASX company

REA Group runs Australia’s dominant property listings platform realestate.com.au and earns revenue primarily from agents paying for property advertising and premium listings.

Its strong market share and network effects have historically made it one of the highest quality digital businesses on the ASX.

The main strength of the S&P/ASX 200 Index (ASX: XJO) share is its pricing power. Even when property listings slow, the company has been able to offset weaker volumes by increasing advertising yields and selling premium products.

However, the ASX share faces several risks. Housing market activity directly affects listing volumes, and new competition has emerged after US property giant CoStar acquired rival Domain. Analysts are also watching whether the recent slowdown in listings persists.

Even so, brokers remain broadly constructive on the ASX share. The consensus 12-month price target sits around $218, suggesting potential upside of roughly 30% from the current level of $168.88.

Seek: global employment marketplace

Seek operates one of the world’s largest online employment marketplaces, connecting jobseekers with employers across Australia, Asia, and Latin America. Its strong network effects and dominant brand in Australia are key strengths, giving the ASX share pricing power and a large base of recurring customers.

However, the business is cyclical. Hiring activity tends to slow when economic growth weakens, which can pressure job ad volumes and earnings. The ASX share has also faced profitability challenges recently, with earnings volatility and restructuring efforts weighing on investor sentiment.

Despite the share price drop, analysts remain broadly optimistic. The ASX share, that just dropped out of the ASX 50, carries a consensus strong buy rating. Analysts have set an average 12-month price target of about $25.51, which points to a possible gain of 55% from recent levels.

Lendlease Group: prestigious property developments

Lendlease is one of Australia’s largest property and infrastructure groups. Its operations span development, construction, and investment management across Australia, Asia, Europe, and the United States.

The $2.6 billion ASX share has delivered major projects around the world and holds a large pipeline of urban regeneration developments. Its stamp is on Sydney’s Barangaroo and London’s prestigious Elephant & Castle redevelopment.

A key strength is its global development platform. Large mixed-use projects can generate significant long-term value as sites are developed and assets are sold or moved into investment vehicles.

The property company has also been simplifying its structure and selling non-core assets as part of a strategy to focus on higher-return development activities.

However, Lendlease remains exposed to the property cycle. Higher interest rates, construction cost inflation, and weaker real estate investment activity have all weighed on sentiment toward the sector. The company has also experienced earnings volatility in recent years as projects move through different development phases.

Despite price decline of the ASX share, analysts see potential upside if the restructuring strategy delivers stronger returns.

Broker forecasts currently place the average 12-month price target around $5.30 range. This implies a potential plus of 44% from recent trading levels if (property) markets stabilise.

The post 3 ASX shares down 30% (or more) to buy right now appeared first on The Motley Fool Australia.

More reading

• 10 ASX 200 shares to buy after the market selloff
• 3 shares dumped from the ASX 200 index (and 3 new additions)
• 3 ASX 200 shares trading well below brokers’ targets
• 2 ASX stocks to buy and 1 to sell
• 5 ASX shares I’d buy and hold for the next decade

Motley Fool contributor Marc Van Dinther has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

The ASX 200 dropped sharply on Monday after oil prices jumped in response to escalating conflict in the Middle East.

Market pullbacks like this can be unsettling in the short term, but we often look back on them and realise they were incredible buying opportunities.

With that in mind, here are 10 ASX 200 shares that could be worth considering after the recent selloff.

Cochlear Ltd (ASX: COH)

Cochlear is a global leader in implantable hearing solutions. Its products help people with severe hearing loss regain the ability to hear. With an ageing global population and strong demand for hearing solutions, Cochlear has a long runway for growth.

CSL Ltd (ASX: CSL)

CSL is one of Australia’s most successful healthcare companies. Its plasma therapies division and vaccines business provide life-saving treatments to patients around the world. Demand for the biotech’s therapies is expected to grow steadily as global healthcare needs expand. And while its recent performance has been disappointing, it could be worth being patient with this ASX 200 share.

Goodman Group (ASX: GMG)

Goodman Group develops and manages logistics facilities and data infrastructure across major global cities. Its warehouses support ecommerce supply chains while its data centre developments benefit from the rapid growth of cloud computing and artificial intelligence (AI).

Light & Wonder Inc. (ASX: LNW)

Another ASX 200 share to look at is Light & Wonder. It is a global gaming technology company operating across casino gaming, digital gaming, and social gaming. Its portfolio of games and platforms provides exposure to the growing global gaming and entertainment industry.

Pro Medicus Ltd (ASX: PME)

Pro Medicus could be worth a shout after recent weakness. It develops medical imaging software used by hospitals and healthcare providers around the world. Its Visage platform is widely regarded as one of the most advanced radiology imaging systems available, supporting strong contract wins and long-term growth.

REA Group Ltd (ASX: REA)

REA Group operates realestate.com.au, Australia’s leading online property marketplace. Its dominant position gives it strong pricing power and recurring revenue from real estate listings and related services.

ResMed Inc. (ASX: RMD)

ResMed specialises in devices and software for treating sleep apnoea and other respiratory conditions. Millions of people remain undiagnosed globally, providing significant long-term demand for this ASX 200 share’s sleep therapy products.

TechnologyOne Ltd (ASX: TNE)

TechnologyOne is a leading enterprise software provider focused on government, education, and large organisations. Its transition to a cloud-based software model has improved recurring revenue and strengthened customer retention.

WiseTech Global Ltd (ASX: WTC)

WiseTech develops logistics software used by freight forwarders and global supply chains. Its CargoWise platform helps businesses manage complex international trade processes, positioning the company to benefit from long-term growth in global logistics.

Xero Ltd (ASX: XRO)

A final ASX 200 share that could be a buy is Xero. It provides cloud-based accounting software for small and medium-sized businesses. With millions of subscribers across multiple markets, the company continues to expand its ecosystem of financial tools and services. And with an estimated total addressable market of 100 million businesses, it has a very long growth runway.

The post 10 ASX 200 shares to buy after the market selloff appeared first on The Motley Fool Australia.

More reading

• 3 ASX shares down 30% (or more) to buy right now
• 3 ASX 200 shares at 52-week lows I’d buy before they recover
• 5 things to watch on the ASX 200 on Tuesday
• 1 ASX growth share down 36% to buy right now
• Why the CSL share price just hit a 9-year low

Motley Fool contributor James Mickleboro has positions in CSL, Cochlear, Goodman Group, Pro Medicus, REA Group, ResMed, Technology One, WiseTech Global, and Xero. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has positions in and has recommended CSL, Cochlear, Goodman Group, Light & Wonder Inc, ResMed, Technology One, WiseTech Global, and Xero. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has recommended Pro Medicus. The Motley Fool Australia has positions in and has recommended ResMed, WiseTech Global, and Xero. The Motley Fool Australia has recommended CSL, Cochlear, Goodman Group, Light & Wonder Inc, Pro Medicus, and Technology One. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

Seeing a company hit a 52-week low can make investors nervous. But in many cases, those moments can create opportunities rather than warnings.

Here are three ASX 200 shares currently trading near their lows that I think could be worth considering following this month’s market selloff.

CSL Ltd (ASX: CSL)

CSL has had a tough period by its own very high standards.

The biotechnology giant has faced investor concerns around the underperformance of the key CSL Behring business and a surprise CEO transition that unsettled the market. Those factors have contributed to a significant pullback in the share price.

However, when I step back and look at the business, I still see one of the highest-quality healthcare companies listed on the ASX.

CSL’s plasma therapies remain critical treatments used around the world, and global demand for these products continues to grow over time. The company also has a strong pipeline of new therapies and vaccines that could support future growth.

With the share price well below its previous highs, I think the risk-reward looks more balanced than it has for some time.

Temple & Webster Group Ltd (ASX: TPW)

Temple & Webster has also fallen to a 52-week low this week during the market selloff.

What stands out to me about Temple & Webster is how the business has grown over the past few years. The company operates an asset-light online model that allows it to scale efficiently while avoiding many of the costs faced by traditional furniture retailers. Its large product range, strong brand recognition, and data-driven merchandising approach have helped it build a leading position in online furniture sales in Australia.

While the market may be focusing on short-term consumer spending trends, I still believe the long-term shift toward online retail works in Temple & Webster’s favour.

If the company continues to execute well, the current share price weakness could prove temporary.

Sigma Healthcare Ltd (ASX: SIG)

Sigma Healthcare is another ASX 200 company whose share price has been under pressure.

However, the company’s merger with Chemist Warehouse has transformed its long-term outlook in my view.

The combination creates a vertically integrated pharmacy and wholesale group with significant scale across the Australian healthcare market. Chemist Warehouse is one of the most recognisable pharmacy brands in the country, and its retail network adds a powerful growth engine to Sigma’s distribution platform.

Over time, I think the combined business has the potential to generate stronger earnings growth and improved efficiency through scale.

Sigma’s current share price weakness could offer a compelling opportunity, in my opinion.

Foolish takeaway

A 52-week low doesn’t always mean something is broken. Sometimes it simply reflects market weakness, short-term uncertainty, or shifting sentiment. When that happens, I like to look for companies where the long-term story still makes sense despite the recent weakness.

CSL, Temple & Webster, and Sigma Healthcare all stand out to me as businesses that could have brighter days ahead once market sentiment improves.

The post 3 ASX 200 shares at 52-week lows I’d buy before they recover appeared first on The Motley Fool Australia.

More reading

• 10 ASX 200 shares to buy after the market selloff
• 3 shares I’m buying if this ASX sell-off gets worse
• 5 things to watch on the ASX 200 on Tuesday
• Why the CSL share price just hit a 9-year low
• 3 amazing Australian shares for beginners to buy in March

Motley Fool contributor Grace Alvino has positions in CSL. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has positions in and has recommended CSL and Temple & Webster Group. The Motley Fool Australia has recommended CSL and Temple & Webster Group. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

It’s not often that the ASX share market falls by approximately 3%, something really has to unsettle the market. This time, the ASX sell-off is being driven by oil prices and what effect that could have on inflation and possibly interest rates.

When there is widespread indiscriminate selling, I believe the market is being too harsh on certain names.

I think particular investments could deliver especially strong returns from where they are today. I’m going to outline three investments I have a close eye on.

Tuas Ltd (ASX: TUA)

Tuas is a Singapore-based telecommunications business that has rapidly built up a mobile subscriber base of well over 1 million. It looks to me like it has defensive, stable earnings for this uncertain period.

The business has worked hard to win over customers with a good value offering, which may be particularly appealing at times like this.

Tuas has demonstrated that it’s effective at winning market share and I’m expecting this to continue in the coming years. As it becomes larger, operating leverage is playing out with its operating profit (EBITDA) margin and net profit margin climbing.

Additionally, a planned acquisition of one of its Singaporean competitors is a compelling move because it diversifies its earnings base, removes a competitor and should significantly increase the ASX share’s profitability.

It has been caught up with the ASX sell-off, with the Tuas share price down by around 25% over the last six months, at the time of writing, I’m calling this business a much better value buy today, particularly if it continues growing revenue at a double-digit pace in the coming years.

Global X S&P World Ex Australia GARP ETF (ASX: GARP)

This exchange-traded fund (ETF) is one of the most effective ways to invest for returns, in my view. It’s aiming to own a portfolio of global shares that offer growth at a reasonable price (GARP).

It holds 250 companies across a range of countries and sectors, giving the business pleasing diversification. More importantly than that, in my view, is that the GARP ETF looks at a number of aspects to ensure it’s just owning the best ideas.

There are three elements to its strategy. Growth (sales and earnings per share (EPS) growth) over three years, value (by looming at the earnings to value multiple), and its quality (debt levels and return on equity (ROE)).

This strategy had outperformed the global share market by an average of more than 4% per year over the prior five years. Of course, past outperformance is not a guarantee of future outperformance.  

Temple & Webster Group Ltd (ASX: TPW)

The third ASX share I want to highlight is homewares, furniture and home improvement online retailer Temple & Webster.

At the time of writing, Temple & Webster share price has fallen by around two-thirds over the last six months. In 2026 alone, it has dropped 46%. It has been one of the ones hit hard this year amid the ASX sell-off.

This business has been very volatile over the last several years, yet its revenue has climbed year after year. It’s winning at gaining market share as more shoppers adopt e-commerce. Its revenue from home improvement products is growing particularly strongly, though that’s only a small part of the business at the moment.

Temple & Webster believes its market share can continue to climb as the penetration of online shopping of homewares and furniture continues climbing. If it follows the US trend, then the market could grow to least around 30% online, up from around 20% currently in Australia.

I’m expecting the business to deliver operating leverage as it grows, resulting in higher profit margins. I’m also bullish the ASX share can grow its market share in Australia (and New Zealand).

The post 3 shares I’m buying if this ASX sell-off gets worse appeared first on The Motley Fool Australia.

More reading

• 3 ASX 200 shares at 52-week lows I’d buy before they recover
• How I’d invest $20,000 in the ASX share market right now
• The five worst performing ASX 200 stocks bought and held in February unmasked
• These ASX 200 shares sank 20% or more in February
• 2 ASX growth shares I invested in last week with $4,000

Motley Fool contributor Tristan Harrison has positions in Temple & Webster Group and Tuas. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has positions in and has recommended Temple & Webster Group. The Motley Fool Australia has recommended Temple & Webster Group. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

When markets turn volatile, ASX growth stocks are often the first to come under pressure.

ASX growth stocks NextDC Ltd (ASX: NXT) and Mesoblast Ltd (ASX: MSB) lost big on Monday, falling 6.8% and 8% respectively. By comparison the S&P/ASX 200 Index (ASX: XJO) started the week with a descend of nearly 3%.  

But short-term weakness doesn’t necessarily change the long-term opportunity. In fact, market uncertainty can create attractive entry points for investors willing to take a longer-term view.

With that in mind, let’s have a closer look at these 2 exciting ASX growth stocks.

NextDC: riding the AI-trend

The $9 billion ASX share is riding one of the market’s most powerful structural trends – artificial intelligence. Businesses are rapidly shifting to cloud platforms, deploying AI workloads, and demanding secure, scalable digital infrastructure.

NextDC sits right at the centre of that shift. The ASX growth stock is a leading data centre-as-a-service provider in the Asia-Pacific, supplying critical infrastructure to global cloud platforms, large enterprises, and government clients.

Demand for capacity is accelerating as the cloud transition and the AI boom gather pace. That trend underpins a long runway for earnings growth.

In its first half-year results for 2026, NextDC reported total revenue of $232 million, up 13% year-over-year. Customer demand for data centre capacity also continued to rise, 137% to almost 417 megawatts.

Heavy investment remains a core part of the strategy. The ASX growth stock is directing significant capital toward new facilities to expand its footprint and support growing customer demand.

Broker sentiment remains positive. Some analysts have set a maximum 12-month price target of $31.02, implying potential upside of about 142% from current levels.

The team at Morgans is more conservative but still bullish. The broker recently retained its buy rating on the ASX growth stock and a price target of $20.50, a potential plus of roughly 60% over 12 months.

Mesoblast: high-risk, high-reward biotech

This ASX growth stock offers a very different investment story. Mesoblast is a much higher-risk, potentially higher-reward biotech play.

Mesoblast is an Australian clinical-stage biotech developing and commercialising allogeneic cell therapies for complex diseases. Some treatments are already in use, while others are advancing through late-stage clinical trials.

The company has the potential for strong growth this year. Product adoption is increasing and the business is well funded to support its next phase of expansion.

Commercial momentum is also improving. The latest quarterly update showed US$30 million in net revenue, supported by rising demand for its therapy Ryoncil in the United States.

Even so, risks for the ASX growth stock remain substantial. Mesoblast has spent years funding clinical trials and has consumed significant capital along the way. The cell-therapy market is highly competitive, regulatory setbacks have previously delayed progress, and successful commercial execution is still crucial.

Despite those risks, brokers remain optimistic. According to TradingView data, all covering analysts currently rate the share a strong buy, with targets ranging from $3.21 to $4.92.

The average 12-month price target for the ASX growth stock sits around $4.05, implying potential upside of about 92%.

Analysts at Bell Potter Securities are also constructive. The broker believes the company is well positioned thanks to fresh debt funding and rising demand for Ryoncil, and it has placed a $4.45 price target on the stock. That suggests a possible gain of roughly 110%.

The post 2 exciting ASX growth stocks tipped to storm higher appeared first on The Motley Fool Australia.

More reading

• Should investors buy the dip on these ASX 200 shares?
• Is NextDC the ASX share closest to Nvidia?
• Buy, hold, sell: NextDC, WiseTech Global, and CBA shares
• 2 ASX growth stocks set up for massive gains in 2026+
• 2 Aussie stocks primed to surge in 2026

Motley Fool contributor Marc Van Dinther has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

The Australian share market suffered one of its worst days in a long time yesterday. At the closing bell of Monday’s session, the S&P/ASX 200 Index (ASX: XJO) had crashed 2,85% lower to 8,599 points. That was after closing at 8,851 points on Friday and getting as low as 8,457.2 points (down almost 4.5%) during intra-day trading yesterday. Needless to say, were are a lot of people selling their ASX shares on the market on Monday – far more than are buying.

This market-wide sell-off could well continue today. As such, many investors might be preparing to hit the sell button as soon as the market opens.

It is always tempting to follow the crowd and sell your ASX shares amid this fear. For one, there always an evolution-induced comfort in moving with the crowd. For another, the temptation to sell a stock that has already lost you money ‘before it goes down any further’ can be hard to resist.

Yet I’m here to tell you that selling your stocks in a week this this one is almost always a mistake, and one that could cost you more money that it saves you.

Most of the time, markets behave rationally, assigning valuations based on a company’s expected future profits and cash flows. But occasionally, this rationality is overtaken by emotion, usually fear or greed. An excess of greed tends to builds up over months into what’s commonly called a bubble. The ‘dot-com crash’ of the early 2000s is a great example of how this usually ends.

But fear is the emotion that has clearly taken over investors’ minds this week. Unlike greed, fear can suddenly consume a market, often sparked by some kind of catalytic black swan event.

War roils ASX shares as investors sell

Enter the US-Iran War. Markets were certainly not expecting the major disruption to global energy supplies that this War has resulted in. And it has been major. Brent crude oil went from around US$82 a barrel at the end of last week to over US$110 on Monday. It cannot be overstated how much of a game-changer this could be for the global economy, given the importance of oil and its derivatives as an input to almost every kind of economic activity.

Hence the fear. Investors have cause to be fearful. However, fear isn’t a very good reason to just sell one’s shares. When we buy a share, we should be aiming to purchase a piece of a company that is growing and will continue to grow for the foreseeable future. I like to compare it to buying a house in a suburb with good growth characteristics. That suburb might have issues form time to time. A street might be closed for repair. A house on it could burn down. Vandals could graffiti a wall or trample a neighbourhood garden. The local pub might close for a few months for a renovation. All of these issues can cause short0term pain for residents. But none will conceivably damage that suburb’s long-term desirability.

Keep your eyes on the horizon

It is the same on the share market. Yes, companies could feel acute short-term pain from this latest Middle East war. But the ASX has seen far worse. After all, the 21st century has already seen many wars, a global financial crisis, a dot-com boom and bust, and, of course, a pandemic. Yet it has managed to come out of the other sides of all of these events to reach new record highs. I’d be happy to wager that this time will be no different.

So don’t sell your ASX shares this week because oil just spiked. Instead, do what Warren Buffett would do and try to buy shares of top companies trading at what might be temporarily cheap prices.

The post Thinking of selling your ASX shares today? Here’s why it would be a big mistake appeared first on The Motley Fool Australia.

More reading

• Here are the top 10 ASX 200 shares today
• Why almost every ASX sector is falling in today’s market sell-off
• US$100 oil is a big deal for every ASX share. Here’s why
• If I wanted to outperform the ASX 200 over the next 10 years, I’d focus here
• 5 things to watch on the ASX 200 on Monday

Motley Fool contributor Sebastian Bowen has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

On Monday, the S&P/ASX 200 Index (ASX: XJO) started the week with a very disappointing decline. The benchmark index sank 2.85% to 8,599 points.

Will the market be able to bounce back from this on Tuesday? Here are five things to watch:

ASX 200 set for massive rebound

The Australian share market looks set for a very strong session on Tuesday following a solid start to the week in the US. According to the latest SPI futures, the ASX 200 is poised to open the day 200 points or 2.3% higher. In late trade on Wall Street, the Dow Jones is up 0.5%, the S&P 500 is up 0.8%, and the Nasdaq is 1.4% higher.

Oil prices tumble

It could be a poor session for ASX 200 energy shares Karoon Energy Ltd (ASX: KAR) and Santos Ltd (ASX: STO) after oil prices pulled back overnight. According to Bloomberg, the WTI crude oil price is down 5.25% to US$86.13 a barrel and the Brent crude oil price is down 3.2% to US$89.71 a barrel. This was driven by comments from President Trump, suggesting that the US could take control of the Strait of Hormuz.

Buy Nickel Industries shares

Nickel Industries Ltd (ASX: NIC) shares could be in the buy zone according to analysts at Bell Potter. This morning, the broker has retained its buy rating and $1.45 price target on the nickel producer’s shares. It said: “While the conflict in the Middle East is resulting in an immediate market impact to key input costs and the duration is uncertain, we form the view that while margins may be impacted, NIC is insulated due to its diversified nickel product suite. There is also a potential offset from higher nickel prices to which NIC has strong leverage. We retain our Buy recommendation and leave our $1.45/sh Target Price unchanged.”

Gold price slips

ASX 200 gold shares Evolution Mining Ltd (ASX: EVN) and Ramelius Resources Ltd (ASX: RMS) could have a subdued session on Tuesday after the gold price slipped overnight. According to CNBC, the gold futures price is down 0.25% to US$5,146.5 an ounce. A stronger US dollar and higher rate expectations put pressure on the precious metal.

ASX 200 shares going ex-div

A number of ASX 200 shares are going ex-dividend today and could trade lower. This includes CSL Ltd (ASX: CSL), Coles Group Ltd (ASX: COL), Iress Ltd (ASX: IRE), News Corporation (ASX: NWS), and Qantas Airways Ltd (ASX: QAN). With respect to the latter, the airline operator is paying shareholders a fully franked 19.8 cents per share interim dividend next month on 15 April.

The post 5 things to watch on the ASX 200 on Tuesday appeared first on The Motley Fool Australia.

More reading

• 10 ASX 200 shares to buy after the market selloff
• 3 ASX 200 shares at 52-week lows I’d buy before they recover
• Here are the top 10 ASX 200 shares today
• Why the CSL share price just hit a 9-year low
• Nosedive: Why did Qantas shares crash 9% today?

Motley Fool contributor James Mickleboro has positions in CSL. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has positions in and has recommended CSL. The Motley Fool Australia has recommended CSL. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

Light & Wonder Inc (ASX: LNW) shares have been out of form over the past 12 months.

This has seen the ASX growth share down 36% from its 52-week high.

While this is disappointing for existing shareholders, it could be a buying opportunity for growth investors.

That’s the view of analysts at Bell Potter, who are tipping this gaming technology company’s shares to rise strongly from current levels.

What is the broker saying about this ASX growth share?

Bell Potter was pleased with Light & Wonder’s performance during FY 2025. It notes that its profits were ahead of expectations thanks to margin expansion initiatives. The broker explains:

LNW reported AEBITDA [adjusted EBITDA] of US$1,443m, +1% above BPe and VA consensus. [..] LNW reported +4% YoY revenue growth to US$3,314m below BPe of US$3,337m and consensus of US$3,330m, supported by +6% YoY growth in Gaming (BPe +7%), -3% YoY growth in SciPlay (BPe -2%) and +13% YoY growth in iGaming (BPe +11%). Adj. NPATA of US$567m was up +18% YoY (+1% beat vs. BPe). The Nth. Am. install base grew units to 48.33k, ahead of BPe of 48.00k, with the base business growing by 700 units. The beat to consensus was driven by margin expansion initiatives.

Also going down well with the broker was management’s outlook commentary. It notes that the ASX growth share is working towards its US$2 billion AEBITDA target and is expecting another year of strong profit growth. It adds:

LNW continues to work towards US$2.0b AEBITDA target. For CY26 LNW forecasts another year of strong Adjusted NPATA and EPSa growth. The company anticipates the shape of earnings to be broadly similar to CY25 reflective of a growing recurring revenue base and industry cyclicality. Strategic investments, tariff costs in Gaming and legacy costs pertaining to legal matters are anticipated in 1H26 (1Q26 in particular.)

Outsized returns

In light of this, Bell Potter has a buy rating and $220.00 price target on the ASX growth share.

Based on its current share price, this implies potential upside of over 75% for investors over the next 12 months.

The broker revealed that it is bullish on the stock due to its belief that artificial intelligence (AI) will not disrupt its business model. It explains:

We rate LNW a Buy due to a compelling GARP profile relative to the ASX 100 and ALL. We expect a continuation in the re-rate observed since the ASX sole listing in November 2025, as long as the company executes on its strategy. We believe LNW’s heightened investment in R&D will drive continued growth, particularly in the Premium leased market. Further, we believe LNW’s R&D engine is difficult to replicate by AI and therefore gives the company an enduring moat.

The post 1 ASX growth share down 36% to buy right now appeared first on The Motley Fool Australia.

More reading

• What to make of these volatile ASX shares
• 3 shares dumped from the ASX 200 index (and 3 new additions)
• Top brokers name 3 ASX shares to buy next week
• Morgans names 3 ASX shares to buy in March
• Here are the top 10 ASX 200 shares today

Motley Fool contributor James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has positions in and has recommended Light & Wonder Inc. The Motley Fool Australia has recommended Light & Wonder Inc. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

The potential of assets to grow our wealth over the long term becomes increasingly powerful as the numbers compound. Putting money towards ASX shares each day, week, or month could make a huge difference to how much wealth we have in the coming years.

How much do we need to invest to become wealthy? Depends on how wealthy you want to be and how long you have to achieve that goal.

It’d be great to invest $100,000 every year, but not many households have a financial picture like that.

For Aussies serious about building wealth, reaching $1 million will require significant effort, choices, and patience. It’ll require attention on the expenses and/or income side of things.

I’m going to show how putting $50 per day into an ASX share portfolio can deliver results. But investing more or less than that would also be a worthwhile thing to do, depending on a household’s finances.

Investing $50 per day into ASX shares

I’m not suggesting that Aussies make an investment every single day. Doing so once a month or so would probably be a good call. If someone saved $50 per day for 30 days, that would be $1,500. I’d suggest around $1,000 would be a bare minimum because that could help minimise brokerage costs.

Over a year, saving $50 per day would translate into investing $18,250. Again, I’ll point out that investing $5,000, $10,000, or $25,000 over a year would also be a great thing to do for our finances. But I’ll show how $50 per day can develop.

I’d need a working crystal ball to know how good the returns are going to be in the coming years.

Past performance is not a guarantee, or even a reliable indicator, of future returns. But it shows the types of returns an investment can produce.

The ASX share market – which I think the Vanguard Australian Shares Index ETF (ASX: VAS) is a good proxy for – has returned an average of 10% per year over the ultra-long-term. If someone invested $50 per day and earned an average of 10% per year, it would grow to $1 million after 20 years.

The global share market could be a better place to invest for long-term returns because of the earnings growth potential and the strength of the businesses involved. I like the Vanguard MSCI Index International Shares ETF (ASX: VGS) as a way to invest in the global share market – it has returned an average of 13.4% per year over the past decade. Investing $50 per day would grow to $1 million in 17 years at that pace.

I think there are plenty of investments that could outperform these two over time, which is what I look for.

The post How investing $50 a day into ASX shares could become $1 million faster than you think appeared first on The Motley Fool Australia.

More reading

• 4 ASX ETFs to ride through recessions and market crashes
• What I’d buy if the ASX share market crashes
• 2 ETFs I’d buy and hold for the next 20 years
• 4 reasons not to panic-sell ASX shares during March
• The easy way to build a diversified ASX share portfolio

Motley Fool contributor Tristan Harrison has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has recommended Vanguard Msci Index International Shares ETF. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

Well, it was about as bad a start to a trading week as can possibly be for the S&P/ASX 200 Index (ASX: XJO) and most ASX shares this Monday. After a rough week last week, investors returned to the ASX boards in sheer panic today.

Thanks largely to shocks on global energy markets rolling through the world’s economy, investors hit the sell button hard this session, sending the ASX 200 down by a horrific 2.85%. That leaves the index at just 8,599 points after it finished at 8,851 points last Friday.

This depressing start to the Australian trading week comes after a tough end to the American week on Saturday morning (our time).

The Dow Jones Industrial Average Index (DJX: .DJI) suffered a sizeable drop of 0.95%.

The tech-heavy Nasdaq Composite Index (NASDAQ: .IXIC) was hit even harder, falling by 1.59%.

But let’s grit our teeth and return to this week and our local markets now for an autopsy of the various ASX sectors‘ performance this Monday.

The post Here are the top 10 ASX 200 shares today appeared first on The Motley Fool Australia.

More reading

• Why almost every ASX sector is falling in today’s market sell-off
• Woodside shares edge higher as Meg O’Neill prepares to take the top job at BP
• Buy, hold, sell: Whitehaven Coal, Goodman, and Xero shares
• US$100 oil is a big deal for every ASX share. Here’s why
• Why Amplitude Energy, Cogstate, Dexus Convenience Retail, and Santos shares are charging higher

Motley Fool contributor Sebastian Bowen has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has recommended Collins Foods. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.